NCT Number: NCT02310815
ReSure Sealant Post Approval Study
This is a prospective multicenter observational post-approval registry study that will collect post-approval data relative to the incidence of pre-specified Adverse Ocular Events for cataract surgery patients treated with the FDA-approved ReSure Sealant when used by a broad group of physicians under commercial use conditions.
Looking for future studies?
Notify MeKey information
Conditions
Age range
22 year and older
Sex eligibility
All sexes
Study type
Observational
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Subject has a cataract and is expected to undergo clear corneal cataract surgery with intraocular lens placement
Exclusion criteria
- ReSure Sealant is not applied to the operative eye
Treatment and study plan
Primary outcomes
-
Anterior chamber cells greater than level 1+ persisting at Visit 2 (≥ Day 20)
Time frame: Post operative days 20 to 40
-
Hypotony (≤ 5 mmHg)
Time frame: Post operative days 20 to 40
-
Ocular discomfort
Time frame: Post operative days 20 to 40
Ocular Comfort Index score greater than 51.7 or a within-person increase from baseline of greater than 37.8
-
Surgical reintervention
Time frame: Post operative days 20 to 40
Surgical reintervention for management of a wound leak - Yes or No
Sponsors and collaborators
Lead sponsor
Ocular Therapeutix, Inc.
Industry
Registry information
Official study title
ReSure Sealant Post-Approval Study: A Registry Evaluation of ReSure Sealant for Specified Adverse Ocular Events After Sealing Corneal Incisions in Patients Undergoing Clear Corneal Cataract Surgery
Acronym: Clinical PAS
Important dates
- Study start
- 2014
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Dec 8, 2014
- Registry last updated
- Dec 5, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The IGBallon (R) - for Use in the Treatment of Obesity
NCT07647991
Adverse Events, Body Weight
Vienna, State of Vienna, Austria
View Trial DetailsABM/P-15 Bone Graft vs Traditional Bone Graft in Adult Spinal Deformity Surgery
NCT05038527
Adverse Events, Bone Graft; Complications
Copenhagen, Denmark
View Trial DetailsImpact of SCFA Supplementation on Metabolic Profiles in Serum and Urine of Kidney Transplant Recipients.
NCT06951581
Adverse Events, Immunosuppressive Agents
Martin, Slovakia
View Trial DetailsRetrospective Independent Safety Review of Closed Irrisept Study
NCT05359666
Adverse Events
Tucson, Arizona, United States
View Trial Details